Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse

被引：0
|
作者：
C Kahlert
H Weber
C Mogler
F Bergmann
P Schirmacher
H G Kenngott
U Matterne
N Mollberg
N N Rahbari
U Hinz
M Koch
M Aigner
J Weitz
机构：
[1] University of Heidelberg,Department of Surgery
[2] Im Neuenheimer Feld 110,undefined
[3] Institute of Pathology,undefined
[4] University of Heidelberg,undefined
[5] Im Neuenheimer Feld 110,undefined
[6] Institute of Occupational and Social medicine,undefined
[7] Voßstrasse 2,undefined
来源：
British Journal of Cancer | 2009年 / 101卷
关键词：
ALCAM; CD166; ADAM17/TACE; pancreatic cancer; prognostic marker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：457 / 464
页数：7
相关论文
共 50 条
  • [31] CD44 variant expression is a poor prognostic marker in early gastric cancer and well-differentiated gastric cancer
    Lee, Won Sup
    Go, Se-Il
    Lee, Jeong-Hee
    Jeong, Sang-Ho
    Lee, Young-Joon
    Hong, Soon Chan
    Ha, Woo Song
    Ko, Gyung Hyuck
    CANCER RESEARCH, 2014, 74 (19)
  • [32] ADAM9 Expression is a Significant and Independent Prognostic Marker of PSA Relapse in Prostate Cancer
    Fritzsche, Florian R.
    Jung, Monika
    Toelle, Angelika
    Wild, Peter
    Hartmann, Arndt
    Wassermann, Kirsten
    Rabien, Anja
    Lein, Michael
    Dietel, Manfred
    Pilarsky, Christian
    Calvano, Daniela
    Gruetzmann, Robert
    Jung, Klaus
    Kristiansen, Glen
    EUROPEAN UROLOGY, 2008, 54 (05) : 1097 - 1108
  • [33] Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker
    Bragantini, E
    Barbi, S
    Beghelli, S
    Moore, PS
    de Manzoni, G
    Roviello, F
    Tomezzoli, A
    Vindigni, C
    Baffa, R
    Scarpa, A
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (01) : 45 - 50
  • [34] Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker
    Emma Bragantini
    Stefano Barbi
    Stefania Beghelli
    Patrick S. Moore
    Giovanni de Manzoni
    Franco Roviello
    Anna Tomezzoli
    Carla Vindigni
    Raffaele Baffa
    Aldo Scarpa
    Journal of Cancer Research and Clinical Oncology, 2006, 132 : 45 - 50
  • [35] High ERG expression is an independent prognostic marker for impaired relapse free survival in patients with acute promyelocytic leukemia
    Nolte, F.
    Hecht, A.
    Nowak, D.
    Nowak, V.
    Hanfstein, B.
    Faldum, A.
    Buechner, T.
    Spiekermann, K.
    Sauerland, C.
    Lengfelder, E.
    Hofmann, W-K
    ONKOLOGIE, 2012, 35 : 175 - 175
  • [36] Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer
    Elin Sjöberg
    Martin Augsten
    Jonas Bergh
    Karin Jirström
    Arne Östman
    British Journal of Cancer, 2016, 114 : 1117 - 1124
  • [37] CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients
    Kristiansen, G
    Schlüns, K
    Yongwei, Y
    Denkert, C
    Dietel, M
    Petersen, I
    BRITISH JOURNAL OF CANCER, 2003, 88 (02) : 231 - 236
  • [38] CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival
    Kristiansen, G
    Denkert, C
    Schlüns, K
    Dahl, E
    Pilarsky, C
    Hauptmann, S
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (04): : 1215 - 1221
  • [39] Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer
    Sjoberg, Elin
    Augsten, Martin
    Bergh, Jonas
    Jirstrom, Karin
    Ostman, Arne
    BRITISH JOURNAL OF CANCER, 2016, 114 (10) : 1117 - 1124
  • [40] CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients
    G Kristiansen
    K Schlüns
    Y Yongwei
    C Denkert
    M Dietel
    I Petersen
    British Journal of Cancer, 2003, 88 : 231 - 236
12345